Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of pharmaceutical sciences"
DOI: 10.1016/j.xphs.2019.09.006
Abstract: Although N-methyl-D-aspartate receptors (NMDAR) antagonists are hopeful therapeutic agents against cerebral ischemia/reperfusion (I/R) injury, effective approaches are needed to allow such agents to pass through the blood-brain barrier (BBB), thus increasing bioavailability of the antagonists…
read more here.
Keywords:
weakly acidic;
cerebral ischemia;
encapsulated ifenprodil;
ischemia reperfusion ... See more keywords